This document provides guidelines for exercise prescription for patients who have experienced an acute coronary syndrome (ACS). It discusses that exercise training can improve outcomes for ACS patients by enhancing exercise tolerance, quality of life, and reducing cardiovascular risk factors. The guidelines recommend that ACS patients complete cardiac rehabilitation, including both aerobic and resistance training exercises. Aerobic exercise should be 3-5 days per week at a moderate intensity based on heart rate, and resistance training 2-3 days per week focusing on major muscle groups. Exercise prescriptions must ensure the ischemic threshold is not exceeded to prevent anginal symptoms.
Exercise Training Recommendation for Individual with Chronic Stable Angina an...nihal Ashraf
For patients with cardiovascular disease, exercise is a critically important intervention and should be prioritized to slow the progression of disease and prevent or reverse physical deconditioning.
Glimpse of Cardiac rehabilitation for health care professionals to update themselves, with aim of helping people with or without disease. Focus on primary, secondary, tertiary prevention.
It is to allow the therapist to formulate an accurate assessment of the clinical status of the patient
Severity of the disease
Stability of the symptoms
Presence of other co-morbidities other than
the primary diagnosis
Exercise Training Recommendation for Individual with Chronic Stable Angina an...nihal Ashraf
For patients with cardiovascular disease, exercise is a critically important intervention and should be prioritized to slow the progression of disease and prevent or reverse physical deconditioning.
Glimpse of Cardiac rehabilitation for health care professionals to update themselves, with aim of helping people with or without disease. Focus on primary, secondary, tertiary prevention.
It is to allow the therapist to formulate an accurate assessment of the clinical status of the patient
Severity of the disease
Stability of the symptoms
Presence of other co-morbidities other than
the primary diagnosis
Definition, epidemiology, physiology, effects of physical inactivity, benefits of habitual physical activity, contraindications, phases, physical assessment, exercise sessions, description of cardiac rehabilitation program phase II @ University Hospital University of Puerto Rico School of Medicine
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online
Cardiac Rehabilitation has been defined as:
Coordinated, multifaceted interventions designed to optimize a cardiac patient’s physical, psychological, and social functioning so that they may, by their own efforts, resume and maintain as normal a place as possible in the community
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
Definition, epidemiology, physiology, effects of physical inactivity, benefits of habitual physical activity, contraindications, phases, physical assessment, exercise sessions, description of cardiac rehabilitation program phase II @ University Hospital University of Puerto Rico School of Medicine
International Journal of Pharmaceutical Science Invention (IJPSI)inventionjournals
International Journal of Pharmaceutical Science Invention (IJPSI) is an international journal intended for professionals and researchers in all fields of Pahrmaceutical Science. IJPSI publishes research articles and reviews within the whole field Pharmacy and Pharmaceutical Science, new teaching methods, assessment, validation and the impact of new technologies and it will continue to provide information on the latest trends and developments in this ever-expanding subject. The publications of papers are selected through double peer reviewed to ensure originality, relevance, and readability. The articles published in our journal can be accessed online
Cardiac Rehabilitation has been defined as:
Coordinated, multifaceted interventions designed to optimize a cardiac patient’s physical, psychological, and social functioning so that they may, by their own efforts, resume and maintain as normal a place as possible in the community
The 6-minute walk test (6MWT) is an easy to perform and practical test that has been used in the assessment of patients with a variety of cardiopulmonary diseases including pulmonary arterial hypertension (PAH). It simply measures the distance that a patient can walk on a flat, hard surface in a period of 6 minutes.
Introduction to exercise electrocardiographyJavidsultandar
Exercise electrocardiography is a Non- invasive tool to evaluate the cardio vascular system's response to exercise under carefully controlled conditions.
Exercise is the body’s most common physiologic stress- most practical test of cardiac perfusion and function.
During exercise body increases its metabolic rate to greater than 20 times that of rest; cardiac out put as much as six fold. (depends on age,sex,type of exercise,size etc)
Evaluation of functional capacity, heart rate changes, burden of ectopy, and dynamic electrocardiographic changes during and after exercise have emerged as powerful prognostic indicators
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
2. exercise prescription for patients with acute coronary syndrome
1. Exercise prescription for patients with
Acute Coronary Syndrome
Hiba Anis
MPT 3rd Sem
Jamia Millia Islamia
2. Acute coronary syndrome (ACS)
• Coronary artery disease (CAD) remains the first cause of mortality worldwide
• Among all types of coronary artery diseases, acute coronary syndrome (ACS) is
the most serious one
• Acute coronary syndrome (ACS, formerly called ischemic heart disease) refers to
a large spectrum of clinical conditions which is caused by a sudden onset of
cardiac tissue ischemia secondary to impaired blood flow.
• The precipitating event is blockage in the coronary arteries or a mismatch between
the demand and supply of blood to cardiac tissue
3. • There is dysfunction of cardiac muscle due to decreased blood flow in the coronary
arteries.
• The resulting tissue ischemia can cause symptoms such as substernal chest pressure;
radiation of pain to the left arm, shoulder, or jaw; and changes on an
electrocardiogram (ECG).
• It clinically manifests as an acute condition, but is actually an acute onset of chronic
systemic vascular disease (atherosclerosis) that has been progressing slowly over a
long period
• ACS is usually divided into three categories:
1. ST elevation myocardial infarction (STEMI, 30%),
2. Non ST elevation myocardial infarction (NSTEMI, 25%), or
3. Unstable angina (38%)
4. Pathophysiology
• characterized by the formation of an atherosclerotic plaque following a long-term
and complex process.
• Most of the time patients would remain asymptomatic if the plaque is stable.
• Once ruptures, it can cause partial or complete occlusion of a coronary artery.
• The rupture of plaque exposes the collagen underneath the endothelial, which may
result in cascade of platelets activation, leading to thrombus formation.
• Several factors may make plaque prone to rupture, like systemic inflammatory
reactions, local shear stress, platelet hyperactivity, prothrombotic states caused by
smoking, dehydration, infection, cocaine, malignancy and so on
• The reduction of blood flow results in these typical angina symptoms
5. • Patients with complete occlusion generally present with ST Elevated Myocardial
infarction (STEMI) .
• If the occlusion is unresolved in a timely manner, it may result in transmural
infarction. This provides the rationale for early reperfusion with either
pharmacological or catheter-based approaches.
• Patients with partially occluded coronary arteries usually presented with other ST-T
changes on EKG.
• These presentations are grouped as Unstable Angina (UA) or Non ST Elevated
Myocardial Infarction (NSTEMI), depending on whether the troponin is elevated
or not.
6.
7. Exercise and ACS
• Exercise training has been demonstrated to improve exercise tolerance, quality of
life, functional capacities and job-related physical tasks, as well as decrease
cardiovascular risk factors and cardiac mortality.
• exercise is a critically important intervention and should be prioritized to slow the
progression of disease and prevent or reverse physical deconditioning
8. Cardiac rehabilitation
• Cardiac rehabilitation (CR) is a long-term program that involves prescribed
exercise, education, and counseling to limit physiological and psychological
effects of cardiac disease and to enhance the psychosocial and vocational status of
selected patients. (Thomas R et al. 2007)
• Recent studies on the effects of CR found that the exercise component of CR
improves ACS individual’s QOL, regardless of the type of coronary syndrome and
type and setting of CR
• US guidelines recommend CR for all patients after CABG, with the referral
ideally performed early postoperatively during the surgical hospital stay (AHA
2015) and all eligible patients with ACS, or those whose status is immediate post
CAB surgery or post PCI should be referred to a comprehensive outpatient CR
program either prior to hospital discharge or during the first follow-up office visit
(AHA 2011)
9. Preparticipation health screening
• After experiencing a cardiac event and prior to starting an exercise training
program, medical clearance is recommended
• Baseline evaluation/ Assessment review
• Medical and surgical history
• most recent cardiovascular event,
• comorbidities, and
• other pertinent medical history
• Current medications
• Dose,
• means by which the drug is administered,
• frequency
10. • Cardiovascular risk factors should be identified
• Physical examination
• Cardiopulmonary system
• musculoskeletal systems
• The baseline physical examination should be performed by a physician or other
appropriate health care provider under the direction of a physician who is actively
involved in the care of patients
• Identification of contraindications for exercise training have been developed and
should be considered prior to having an individual with coronary artery disease
initiate an exercise training program
11. Exercise Testing Considerations
• Symptom-limited cardiopulmonary exercise test
• Symptom-limited cardiopulmonary exercise testing is currently accepted as a standard
in CR programs for patients after ACS
• Assessing the risk of participation in exercise-induced CR programs based on changes
in HRs, abnormal ECGs, changes in BP, and the onset of symptoms as a result of
increasing exercise load can be used to develop safe and effective exercise
prescriptions
• Submaximal exercise test (6-minute walk test)
• Where maximal exercise testing is difficult, a submaximal exercise test, such as a 6-
minute walk test, is commonly recommended
• a 6-minute walk distance is used to set exercise intensity and evaluate the
effectiveness of CR
12. • For all patients, regardless of whether an exercise tolerance test is
administered, RPE should be used as a tool to guide and adjust
exercise intensity while maintaining patients within their physical
limitations and below their symptomatic threshold
13. Exercise prescription
• Early CR is usually recommended if PCI is performed for ACS. In cases of
CABG, CR may be delayed due to concerns about general deconditioning and the
recovery of the sutured site after sternotomy
• Prescriptive techniques for determining exercise dosage or the frequency,
intensity, time, and type (FITT) of an exercise prescription for chronic stable
angina and coronary artery bypass surgery patients are followed
14. Aerobic exercise
• Frequency : Minimal 3 d/wk ; preferably 5 d/wk
• Intensity: With an exercise test, use 40%– 80% of exercise capacity, using HRR,
VO2peak . Without an exercise test, use seated or standing HRrest + 20– 30 bpm
or an RPE of 12–16 on a 6–20 scale
• Time : 20-60 mins
• Type: Arm ergometer, upper and lower (dual action) extremity ergometer, upright
and recumbent cycles, recumbent stepper. activities that employ large muscle
groups through rhythmic activities such as walking, jogging, cycling, elliptical,
stair climbing, and rowing.
15. Resistance training
• the American Heart Association (AHA) (2011) reports that resistance exercise
improves muscle strength, endurance, fitness, independence, and QOL, regardless
of the presence of CVD.
• One limitation of these studies on the reported effects of resistance training,
however, was that they were generally small-scale studies involving low-risk
groups for exercise-related adverse CV events. Thus, the AHA (2011) presents the
absolute and relative contraindications of resistance exercise
16. • Absolute
• Unstable coronary heart disease
• Decompensated heart failure
• Uncontrolled arrhythmias
• Severe pulmonary hypertension (mean pulmonary arterial pressure>55 mmHg)
• Severe and symptomatic aortic stenosis
• Acute myocarditis, endocarditis, or pericarditis
• Uncontrolled hypertension (>180/110 mmHg)
• Aortic dissection
• Marfan syndrome
• High-intensity RT (80–100% of 1-RM) in patients with active proliferative
retinopathy or moderate or worse non-proliferative diabetic retinopathy
17. • Relative (should consult a physician before participation)
• Major risk factors for coronary heart disease
• Diabetes at any age
• Uncontrolled hypertension (>160/100 mmHg)
• Low functional capacity (<4 Metabolic equivalents of task)
• Musculoskeletal limitations
• Individuals with implanted pacemakers or defibrillators
(Kim, C., Sung, J., Lee, J. H., Kim, W. S., Lee, G. J., Jee, S., Jung, I. Y., Rah, U. W., Kim, B. O., Choi, K. H., Kwon, B. S., Yoo, S. D., Bang,
H. J., Shin, H. I., Kim, Y. W., Jung, H., Kim, E. J., Lee, J. H., Jung, I. H., Jung, J. S., … Kim, S. (2019). Clinical Practice Guideline for
Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary
Syndrome. Korean circulation journal, 49(11), 1066–1111. https://doi.org/10.4070/kcj.2019.0194)
18. • Resistance training results in improved muscle strength and endurance, both of which
are important for the safe return to ADL along with occupational and avocational
pursuits
• Frequency : 2–3 d/wk −1 (nonconsecutive) at 40%–60% 1RM or RPE ~11–13 (6–
20 scale)
• Volume: 10–15 repetitions. Without fatigue,1–3 sets per exercise for 8–10
different muscle groups
• Type: Select equipment that is safe for the patient to use.
• Proper form should be maintained through the entirety of the range of motion and
individuals should be counseled to refrain from holding their breath during resistance
training
• Patients should be instructed to exhale during the concentric phase of the exercise and
to inhale during the eccentric contraction.
19. • Patients undergoing a catheterization with or without percutaneous intervention
and those who experienced an uncomplicated myocardial infarction may begin
resistance training program as early as 3 and 5 weeks from the date of the event,
respectively
• It is generally recommended that for patients undergoing CABGS involving
sternotomy, upper body resistance training should be avoided for 8–12 weeks from
the date of surgery or until sternal healing has fully occurred.
• Initiating lightweight resistance training prior to when the weight restrictions are
removed, however, is useful to promote range of motion and to minimize muscle
atrophy
20. Special considerations
• Special considerations for those with angina to stay below the ischemic threshold;
• medications such as βblockers, nitrates, and calcium channel blockers may
influence the ischemic threshold.
• Patients with CABGS with sternotomy need to ensure that the sternum is fully
healed and stable.
• Significant restrictions for upper body activities for up to 8–12 wk from the date
of surgery.
• Encourage patients with CABGS to start to exercise prior to 12 wk
• Any increase or change in anginal symptoms should be recorded and receive
immediate medical attention as it may reflect a change in coronary status.
21. • The exercise session should include a prolonged warm-up and cool down (~10
minutes), both of which may have an antianginal effect, and consist of range of
motion, stretching, and low-level aerobic activities. The goal of the warm-up is to
gradually raise the heat rate response within 10 to 20 bpm of the lower limit
prescribed for endurance training.
• Because symptomatic or silent ischemia may be arrhythmogenic, the THR for
endurance exercise should be set safely below (~10bpm) the ischemic ECG or
anginal threshold. Alternatively, the upper heart level can be set as the highest
"nonischemic" workload from the GXT.
22. • If anginal symptoms are not relieved by termination of exercise or by the use of
three sublingual nitroglycerin tablets (one taken every 5 minutes), the patient
should be transported to the nearest hospital emergency center.